Cargando…

ToRCH-screening in pediatric cataract revisited: A North Indian tertiary care centre study

PURPOSE: To analyze and report ToRCH-serology screening profile (Toxoplasma gondii [TOX], rubella [RV], cytomegalovirus [CMV], and herpes simplex virus [HSV-I/II]) in pediatric cataract. METHODS: In this prospective analytical study, 1,026 consecutive children were screened, of which 46 children wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Dasgupta, Sushobhan, Shakeel, Tarannum, Roy, Reshmi Chanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350428/
https://www.ncbi.nlm.nih.gov/pubmed/32317443
http://dx.doi.org/10.4103/ijo.IJO_1141_19
_version_ 1783557265713790976
author Dasgupta, Sushobhan
Shakeel, Tarannum
Roy, Reshmi Chanda
author_facet Dasgupta, Sushobhan
Shakeel, Tarannum
Roy, Reshmi Chanda
author_sort Dasgupta, Sushobhan
collection PubMed
description PURPOSE: To analyze and report ToRCH-serology screening profile (Toxoplasma gondii [TOX], rubella [RV], cytomegalovirus [CMV], and herpes simplex virus [HSV-I/II]) in pediatric cataract. METHODS: In this prospective analytical study, 1,026 consecutive children were screened, of which 46 children with clinically diagnosed congenital (n = 26) and developmental cataract (n = 20) were included. Post-traumatic and familial cataracts were excluded. Sera of all children were tested both qualitatively and quantitatively for IgG/IgM-antibodies against ToRCH agents in a sequential manner. RESULTS: Overall, IgM/IgG-seropositivity against ≥1 ToRCH agent was reported in 91.3% (42/46) children. IgM (±IgG) positivity against ≥1 ToRCH agent was reported in 26.08% (12/46) children (nine congenital and three developmental cataract; P = 0.18), which included 8.7% (4/46) children reported positive against ≥2 agents. Finally, 13% (6/46) children were reported to be sero-clinical-positive (three were infants and three were >1 year age, P = 0.55; five congenital and one developmental cataract, P = 0.21). Either alone or combined, RV attributed to the majority (50%; 6/12) of the IgM (±IgG) and sero-clinical-positive (50%; 3/6) children. None of the children were HSV-II IgM-positive. Laboratory-confirmed congenital rubella syndrome was reported in 4.3% (2/46) children. One sero-clinical-positive infant with rare coexisting bilateral persistent fetal vasculature was also reported. IgG-alone positivity was reported highest with CMV in 67.4% (31/46) children, whereas 43.4% (20/46) children were found nonimmune to RV. CONCLUSION: The current study emphasizes the need to interpret ToRCH-screening in pediatric cataract with caution. Interpretation should include both serial qualitative and quantitative assays in tandem with clinical correlation to minimize the diagnostic errors. Clinicians should remain vigilant regarding sero-clinical-positivity in older children too who might pose a threat to the spread of infection.
format Online
Article
Text
id pubmed-7350428
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-73504282020-07-15 ToRCH-screening in pediatric cataract revisited: A North Indian tertiary care centre study Dasgupta, Sushobhan Shakeel, Tarannum Roy, Reshmi Chanda Indian J Ophthalmol Original Article PURPOSE: To analyze and report ToRCH-serology screening profile (Toxoplasma gondii [TOX], rubella [RV], cytomegalovirus [CMV], and herpes simplex virus [HSV-I/II]) in pediatric cataract. METHODS: In this prospective analytical study, 1,026 consecutive children were screened, of which 46 children with clinically diagnosed congenital (n = 26) and developmental cataract (n = 20) were included. Post-traumatic and familial cataracts were excluded. Sera of all children were tested both qualitatively and quantitatively for IgG/IgM-antibodies against ToRCH agents in a sequential manner. RESULTS: Overall, IgM/IgG-seropositivity against ≥1 ToRCH agent was reported in 91.3% (42/46) children. IgM (±IgG) positivity against ≥1 ToRCH agent was reported in 26.08% (12/46) children (nine congenital and three developmental cataract; P = 0.18), which included 8.7% (4/46) children reported positive against ≥2 agents. Finally, 13% (6/46) children were reported to be sero-clinical-positive (three were infants and three were >1 year age, P = 0.55; five congenital and one developmental cataract, P = 0.21). Either alone or combined, RV attributed to the majority (50%; 6/12) of the IgM (±IgG) and sero-clinical-positive (50%; 3/6) children. None of the children were HSV-II IgM-positive. Laboratory-confirmed congenital rubella syndrome was reported in 4.3% (2/46) children. One sero-clinical-positive infant with rare coexisting bilateral persistent fetal vasculature was also reported. IgG-alone positivity was reported highest with CMV in 67.4% (31/46) children, whereas 43.4% (20/46) children were found nonimmune to RV. CONCLUSION: The current study emphasizes the need to interpret ToRCH-screening in pediatric cataract with caution. Interpretation should include both serial qualitative and quantitative assays in tandem with clinical correlation to minimize the diagnostic errors. Clinicians should remain vigilant regarding sero-clinical-positivity in older children too who might pose a threat to the spread of infection. Wolters Kluwer - Medknow 2020-05 2020-04-20 /pmc/articles/PMC7350428/ /pubmed/32317443 http://dx.doi.org/10.4103/ijo.IJO_1141_19 Text en Copyright: © 2020 Indian Journal of Ophthalmology http://creativecommons.org/licenses/by-nc-sa/4.0 This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Original Article
Dasgupta, Sushobhan
Shakeel, Tarannum
Roy, Reshmi Chanda
ToRCH-screening in pediatric cataract revisited: A North Indian tertiary care centre study
title ToRCH-screening in pediatric cataract revisited: A North Indian tertiary care centre study
title_full ToRCH-screening in pediatric cataract revisited: A North Indian tertiary care centre study
title_fullStr ToRCH-screening in pediatric cataract revisited: A North Indian tertiary care centre study
title_full_unstemmed ToRCH-screening in pediatric cataract revisited: A North Indian tertiary care centre study
title_short ToRCH-screening in pediatric cataract revisited: A North Indian tertiary care centre study
title_sort torch-screening in pediatric cataract revisited: a north indian tertiary care centre study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7350428/
https://www.ncbi.nlm.nih.gov/pubmed/32317443
http://dx.doi.org/10.4103/ijo.IJO_1141_19
work_keys_str_mv AT dasguptasushobhan torchscreeninginpediatriccataractrevisitedanorthindiantertiarycarecentrestudy
AT shakeeltarannum torchscreeninginpediatriccataractrevisitedanorthindiantertiarycarecentrestudy
AT royreshmichanda torchscreeninginpediatriccataractrevisitedanorthindiantertiarycarecentrestudy